Global Blog
Get inspired by our latest blog articles.
Compound AI Systems: The Future of Specialized Intelligence
Since its explosive emergence in mid-2022, generative AI has quickly captured global attention. What initially centered on the language modality has since expanded into exciting...
Is GenAI hype dying? – Why now is the best time to build
Generative AI is a game-changer with applications across industries. Companies are actively discussing it, venture capitalists are heavily investing, and both employees and users are...
Is Preference Alignment Always the Best Option to Enhance LLM-Based Translation? An Empirical Analysis
Neural metrics for machine translation (MT) evaluation have become increasingly prominent due to their superior correlation with human judgments compared to traditional lexical metrics
Unleashing the power of AI in Clinical Trials: Key Insights from PFIZER and ARTEFACT - AI for Health Summit
The discussion revolved around the transformative role of AI in clinical trials, supported by insights from Pfizer and Artefact, and highlighted in their collaborative white...
CLARIANE and CNES MEDES at AI for Health - Preventing frailty and AI-geing well
The conversation explores how data and AI are transforming elder care, focusing on the rising demographic of seniors in France, where 20% of the population...
SANOFI, AWS, IKTOS, ELAIA and MIND GROUP at AI for Health - The generative AI revolution for drug discovery
This roundtable explored the transformative role of GenAI in drug discovery, highlighting its potential to optimize processes, accelerate timelines, and foster collaboration in the pharmaceutical...
ROCHE, PULSELIFE and SALESFORCE at the AI for Health Summit - Omni-channel engagement of HCPs in the Age of GenAI
The roundtable focused on the transformative potential of AI and (GenAI) in omni-channel engagement for healthcare professionals (HCPs). The discussion explored how AI reshapes interactions,...
PFIZER at the AI for Health Summit - AI: On a mission to make drug development faster and smarter
Pfizer is leveraging AI to revolutionize drug development. AI is viewed as a game-changer, impacting every stage of the pharmaceutical process, from preclinical research to...
Leaders' POV: Accelerating drug innovation through AI at SERVIER - AI for Health Summit
Servier has approached AI adoption in two phases. Initially, an opportunistic approach focused on proving AI's potential through specific use cases, especially in collaboration with...
AMGEN, BIOGEN, Johnson & Johnson, USE&SHARE, APHP at the AI for Health Summit - Strategic vision for rare diseases
This roundtable at the AI for Health Summit 2024 focused on the use of health data and artificial intelligence to address diagnostic delays and impasses...
Revolutionizing Drug Development: Unleashing the Power of Artificial Intelligence in Clinical Trials
Read the synthesis of Artefact's report and discover insights from healthcare and pharma companies, like Servier, Pfizer, Johnson & Johnson, Google, Elaia, Inato, Klineo, Deemea,...
Market Data Costs Are Rising in Financial Services – Here’s How to Get Them Under Control
With market data costs soaring—some firms reporting increases of up to 50%—controlling these expenses has become a strategic priority for financial services organizations.